Clinical Trial Update: Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting safety and efficacy results for the Omnilink Elite peripheral stent system in de novo or restenotic lesions of the native common …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Omnilink Elite Peripheral Balloon-Expandable Stent System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Peripheral Vascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-10-01